Clinical Trial Update: Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating the safety of combining primaquine with dihydroartemisinin-piperaquine in G6PD-deficient males; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)
• Primaquine (primaquine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 2, Phase 3 | Status: TERMINATED